Aberrant Gene Expression Prostate Carcinoma
NCT00868803 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2025-06-05
Summary
The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.
Conditions
Sponsors & Collaborators
-
Lahey Clinic
lead OTHER
Principal Investigators
-
Kimberly R Christ, PhD · Lahey Clinic
Eligibility
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1995-04-30
- Primary Completion
- 2030-04-30
- Completion
- 2030-04-30
Countries
- United States
Study Locations
More Related Trials
-
Genetic Testing for Men With Metastatic Prostate Cancer
NCT03503097 ·Status: TERMINATED
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Protein Expression in Tumor Tissue Samples From Patients With Cancer of the Oropharynx
NCT00899340 ·Status: COMPLETED
-
Microarray Analysis of Gene Expression and Identification of Progenitor Cells in Lung Carcinoma
NCT00568906 ·Status: TERMINATED
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom
NCT00758173 ·Status: UNKNOWN
-
A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
NCT03871816 ·Status: COMPLETED
-
Collection of Blood From Patients With Prostate Cancer
NCT00923221 ·Status: RECRUITING
-
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT05304858 ·Status: RECRUITING
-
Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia
NCT00898261 ·Status: COMPLETED
-
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551 ·Status: COMPLETED
-
Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up
NCT01098552 ·Status: COMPLETED
-
Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
NCT00242723 ·Status: RECRUITING
-
Microarray Analysis for Human Genetic Disease
NCT00001898 ·Status: COMPLETED
-
A Registry for Hereditary Cancer Risk Assessment and Genetic Testing
NCT04015102 ·Status: COMPLETED
-
Human Tumor Sequencing Project
NCT01608230 ·Status: COMPLETED
-
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
NCT00908739 ·Status: WITHDRAWN
-
Study of Tissue Samples From Patients With Stage I Non-Small Cell Lung Cancer Enrolled on Research Study CALGB-140202
NCT00990873 ·Status: COMPLETED
-
Prostate Tissue BioBank
NCT06659614 ·Status: RECRUITING
-
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
NCT02853097 ·Status: TERMINATED
-
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073 ·Status: RECRUITING
-
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
NCT00095589 ·Status: COMPLETED
-
Urine Proteome of Surgical Patients and Healthy Volunteers
NCT01538823 ·Status: COMPLETED
-
Genomic Profiling in Previously Untreated Metastatic Non-small Cell Lung Cancer
NCT02671045 ·Status: TERMINATED
-
The BARCODE 1 Pilot Study
NCT03158922 ·Status: ACTIVE_NOT_RECRUITING